Pulmatrix, Inc. (PULM)
NASDAQ: PULM · Real-Time Price · USD
1.345
+0.025 (1.89%)
Jun 3, 2026, 9:30 AM EDT - Market open
Pulmatrix Market Cap
Pulmatrix has a market cap or net worth of $4.91 million as of June 3, 2026. Its market cap has decreased by -79.24% in one year.
Market Cap
4.91M
Enterprise Value
1.50M
1-Year Change
-79.24%
Ranking
Category
Stock Price
$1.35
Market Cap Chart
Since June 16, 2015, Pulmatrix's market cap has decreased from $165.85M to $4.91M, a decrease of -97.04%. That is a compound annual growth rate of -27.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 4.82M | -40.81% |
| Dec 31, 2025 | 8.14M | -68.05% |
| Dec 31, 2024 | 25.49M | 275.27% |
| Dec 29, 2023 | 6.79M | -51.89% |
| Dec 30, 2022 | 14.12M | -42.64% |
| Dec 31, 2021 | 24.61M | -39.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bio Green Med Solution | 5.91M |
| BioAtla | 5.85M |
| Mustang Bio | 5.83M |
| CollPlant Biotechnologies | 5.78M |
| Matinas BioPharma Holdings | 5.59M |
| Silo Pharma | 5.41M |
| Dermata Therapeutics | 5.39M |
| TransCode Therapeutics | 5.16M |